资源描述:
《射频和自体肿瘤疫苗联合治疗肝癌临床研究》由会员上传分享,免费在线阅读,更多相关内容在学术论文-天天文库。
1、射频和自体肿瘤疫苗联合治疗肝癌临床研究作者:李荣梅方雄白瑞球刘宁江高焱明巩平【摘要】目的:探讨射频(RF)和新城鸡瘟病毒(NDV)修饰自体肿瘤疫苗(ATV)联合治疗肝癌效果。方法:治疗组28例进行RF联合ATVNDV治疗,对照组22例进行RF治疗。RF共治疗50例75个瘤体,其中3个瘤体8例,2个瘤体9例。术中切取肿瘤组织,进行免疫测定、病理检查,治疗组加作ATVNDV制备。根据瘤体大小设计射频治疗靶点,实施治疗。结果:RF治疗15d后75个瘤体57个完全坏死,12瘤体仅部分坏死,6例囊性变。两组治
2、疗前AFP升高者治疗后降至正常。治疗组治疗后2月CD4+降低、NK、CD3+、CD4+/CD8+升高,生存率1、3、5年分别为72.2%、50.1%、40.4%,对照组为60.5%、43.6%、29.8%。结论:RF联合ATVNDV治疗肝癌瘤体缩小、AFP下降、免疫功能提高均较单纯RF治疗快,生存率提高,可能与ATVNDV应用延迟肿瘤复发有关。【关键词】肝肿瘤・射频・癌症疫苗Theclinicalstudyonhypatocellularcarcinomatreatmen
3、twithradiofrequencycombinedwithautologoustumorvaccinemodifiedNewcastledisease8【ABSTRACT】Objective:Tocomparethetherapeuticefficacyofradiofrequnecy(RF)combinedwithAutologousTumorVaccinemodifiedbyNewcastieDiseas(ATVNDV)onthehepatocarcinomar.Methods:50case
4、sofpatientswithhepatocarcinomatreatedwiththeprocedureinourhospitalsince1999werestudiedAccordingtothehospitalizationorder,28caseswhosehospitalizationordernumberisoddreceivedRFcombinedwithATVNDV,22caseswhosehospitalizationordernumberiseventreatedwithRFon
5、ly;Therewere75tumorbodiestreated.Therewere8caseswith3tumorbodies,9caseswithtumorbodies.Intheoperation,wecutenoughtumortissueforimmunoassayandpathologicalexamination.WeproducedATVNDVadditionallyinthetherapygroup,designedtheRFtherapeutictargetaccordingto
6、thetumorbodysize,thenexecutivedtreatment.Results:After15daysofRFtherapy,57tumorbodieswerecompletelynecrotic,12bodieswithpartialnecrosis,6tumorbodieswerecysticdegeneration.Thehighalphafetoprotein(AFP)levelsdecreasedtonormalinbothgroups.After2months,thel
7、evelsofNK、CD3+、CD4+/CD8+increasedwhileCD4+leveldecreasedinthetherapygroup1,3,5yearsurvivalratewere72.3%,50.1%,40.4%,respectively,inthecombinedtherapeuticgroupand60.5%,43.6%,29.8%,respectively,inthe8controlgroup.Conclusion:ComparedwiththeonlyRFtreatment
8、group,thesizeofthehepatocarcinomatumorbodydiminuted,thelevelofAFPdecreaseandtheimmunologicalfunctionimproveintheRFcombinedwithATVNDVgroupisfaster.ThesurvivalrateintheRFcombinedwithATVNDVgroupislongerthanthatintheonlyRFtherapygroup,which